secwatch.observer — SEC 8-K summary
======================================

Issuer:     SenesTech, Inc. (SNES)
CIK:        0001680378
Form:       8-K
Filed at:   2024-11-12T23:59:59+00:00
Accession:  0001628280-24-047120
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SenesTech Q3 2024 revenue up 51% YTD; gross margin 65% record; operating expenses down 12%
--------------------------------------------------------------------------------

- YTD revenue $1.4M, +51% YoY; Q3 gross margin 65% vs 49% in prior year.
- Operating expenses down 12% in Q3; adjusted EBITDA loss narrowed 21% vs prior year.
- New products Evolve Rat and Evolve Mouse contributed 52% and 17% of Q3 revenue respectively.
- NYC rat contraception pilot bill approved; SenesTech only EPA-registered manufacturer; supply proposal under negotiation.
- International expansion: HK registration, Netherlands multi-pallet order, exclusive distributor selection in India, Pakistan, Chile, Brazil, Taiwan.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1680378/000162828024047120/0001628280-24-047120-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1680378/000162828024047120/snes-20241112.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-047120

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer